<DOC>
	<DOCNO>NCT01694069</DOCNO>
	<brief_summary>Cystic fibrosis inherit disorder lead chronic pulmonary inflammation infection . A majority people cystic fibrosis large quantity bacteria reside lung . One common harmful bacteria call Pseudomonas aeruginosa . Patients cystic fibrosis require frequent therapy intravenous ( I.V . ) antibiotic treat lung infection think cause Pseudomonas aeruginosa . One antibiotic frequently use treat bacteria piperacillin-tazobactam . Piperacillin-tazobactam thought effective constant level drug body . The standard way administer piperacillin-tazobactam give several gram 4 time day 30 minute infusion . An alternative way give piperacillin-tazobactam continuous infusion ; continuous infusion make likely drug remain constant level body . The objective study determine administer piperacillin-tazobactam continuous infusion effective treat people pulmonary exacerbation cystic fibrosis standard 30 minute infusion , 4 time day .</brief_summary>
	<brief_title>Continuous Infusion Piperacillin-tazobactam Treatment Cystic Fibrosis</brief_title>
	<detailed_description>All patient receive combination therapy include piperacillin-tazobactam 400 mg/kg/day ( base piperacillin component , actual body weight ) exceed 16 gram tobramycin 12 mg/kg/day extend interval dosing ( daily ) . Patients randomize continuous infusion group receive one-time loading dose 100 mg/kg 30 minute follow immediately initiation continuous infusion . Other antibiotic activity Pseudomonas aeruginosa allow . Patients may receive antibiotic treatment Staphylococcus aureus deem appropriate . Other treatment pulmonary exacerbation cystic fibrosis leave control treat physician . Patients receive total 14 day therapy . If deem appropriate , patient may discharge home continue receive blind treatment via infusion pump . Patients evaluate complete 14 day course antibiotic ( end therapy ) .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<criteria>1 . Diagnosis cystic fibrosis 2 . 8 year age great 3 . Chronic intermittent infection Pseudomonas aeruginosa define Leeds Criteria 4 . Pulmonary exacerbation define Fuchs et al . 1 . Admission great 48 hour prior enrollment 2 . Isolation Burkholderia spp . respiratory tract culture prior 12 month 3 . Current treatment allergic bronchopulmonary aspergillosis 4 . Pregnant breast feed 5 . History solid organ transplantation 6 . Renal impairment time randomization ( &lt; 40 mL/min calculate CockcroftGault equation24 Â¬for adult Schwartz equation45 &lt; 18 year age ) receipt hemodialysis 7 . Allergy study medication</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>piperacillin</keyword>
	<keyword>tazobactam</keyword>
	<keyword>pseudomonas aeruginosa</keyword>
	<keyword>cystic fibrosis</keyword>
	<keyword>pulmonary exacerbation</keyword>
	<keyword>continuous infusion</keyword>
	<keyword>beta lactam</keyword>
</DOC>